Minodronic acid-d 4

Overview

Minodronic acid -d 4 (YM-529-d 4 ) is deuterium labeled Minodronic acid ( HY-16322 ). Minodronic acid (YM-529) is an FPP synthase inhibitor with an IC 50 of 3 nM, and also an antagonist of P2X2/3 receptors with an IC 50 of 62.7 μM. Minodronic acid induces tumor cell apoptosis and inhibits cell growth. Minodronic acid also suppresses bone resorption. Minodronic acid can be used in research related to osteoporosis and cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > P2X Receptor | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-16322S
• CAS No.: 1807367-80-1
• Molecular Formula: C9H8D4N2O7P2
• Molecular Weight: 326.17
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source